Article: Cut off value of technetium uptake in the differential diagnosis of Graves disease and subacute thyroiditis

Objectives: The aim of this study was to determine whether technetium (Tc) uptake is a relevant method for the differential diagnosis of Graves disease and subacute thyroiditis and calculate its cutoff value in case of its relevancy.

Methods: A total of 69 patients, who were followed up (>3 months) in our hospital for thyrotoxicosis within 2015-2019 were enrolled in the study. Out of these 69 subjects, 39 patients had been diagnosed with Graves disease, and 30 of them had subacute thyroiditis. Biochemical parameters, thyroid scintigraphy, and Tc uptake test results were evaluated.

Results: Tc uptake was significantly higher in the patients with Graves disease than in the patients with subacute thyroiditis (P<0.001). Based on the ROC analysis the Tc uptake cutoff value of 1.55% had an accuracy of 92.9%, with the sensitivity and specificity of 92% and 87%, respectively.

Conclusion: In conclusion, the results of our study suggested that Tc uptake test could be used in the differential diagnosis of Graves disease and subacute thyroiditis. The cutoff value of 1.55% for Tc uptake test may guide in establishing a differential diagnosis between the two diseases.

Citing Articles

The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis.

Shekarian A, Fakhrolmobasheri M, Mazaheri-Tehrani S, Yousefian A, Heidarpour M Endocrine. 2023; 84(1):29-41.

PMID: 38147263 DOI: 10.1007/s12020-023-03655-6.

Quantitative analysis of Tc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions.

Serrano B, Amblard R, Beaumont T, Hugonnet F, Dietz M, Berthier F EJNMMI Phys. 2023; 10(1):45.

PMID: 37522931 PMC: 10390438. DOI: 10.1186/s40658-023-00566-3.

Analysis of the Application Value of Ultrasound Three-Dimensional Speckle Tracking Technology Combined with Thyroid Autoantibodies and Hormones in the Diagnosis and Treatment of Graves' Disease.

Xu Y, Peng S, Qin L, Sun D, Geng J, Liu Q Evid Based Complement Alternat Med. 2022; 2022:7774283.

PMID: 35845595 PMC: 9279017. DOI: 10.1155/2022/7774283.

Comparison of Tc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves' Disease and Thyroiditis.

Jin M, Ahn J, Jo S, Park J, Jeon M, Kim W Nucl Med Mol Imaging. 2022; 56(1):42-51.

PMID: 35186158 PMC: 8828838. DOI: 10.1007/s13139-021-00734-2.

Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a Saudi population.

Alshahrani A, Syed G, Khan A, Numani S, Alnaim A, Alanazi F Ann Saudi Med. 2021; 41(2):86-90.

PMID: 33818150 PMC: 8020644. DOI: 10.5144/0256-4947.2021.86.

References

1.

Cooper D . Hyperthyroidism. Lancet. 2003; 362(9382):459-68. DOI: 10.1016/S0140-6736(03)14073-1. View

2.

Singhal N, Praveen V, Bhavani N, Menon A, Menon U, Abraham N . Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects. Indian J Endocrinol Metab. 2016; 20(2):157-61. PMC: 4792013. DOI: 10.4103/2230-8210.176360. View

3.

Beindorff N, Bartelheimer A, Huang K, Lukas M, Lange C, Huang E . Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm. Nuklearmedizin. 2018; 57(5):181-189. DOI: 10.3413/Nukmed-0978-18-05. View

4.

Sharma M, Aronow W, Patel L, Gandhi K, Desai H . Hyperthyroidism. Med Sci Monit. 2011; 17(4):RA85-91. PMC: 3539526. DOI: 10.12659/msm.881705. View

5.

Baskaran C, Misra M, Levitsky L . Diagnosis of pediatric hyperthyroidism: technetium 99 uptake versus thyroid stimulating immunoglobulins. Thyroid. 2014; 25(1):37-42. PMC: 4291090. DOI: 10.1089/thy.2014.0266. View

6.

Gilbert J . Thyrotoxicosis - investigation and management . Clin Med (Lond). 2017; 17(3):274-277. PMC: 6297572. DOI: 10.7861/clinmedicine.17-3-274. View

7.

Macauley M, Shawgi M, Ali T, Curry A, Howe K, Howell E . Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population. Nucl Med Commun. 2018; 39(9):834-838. DOI: 10.1097/MNM.0000000000000876. View

8.

Maisey M, Natarajan T, Hurley P, Wagner Jr H . Validation of a rapid computerized method of measuring 99mTc pertechnetate uptake for routine assessment of thyroid structure and function. J Clin Endocrinol Metab. 1973; 36(2):317-22. DOI: 10.1210/jcem-36-2-317. View

9.

Uchida T, Suzuki R, Kasai T, Onose H, Komiya K, Goto H . Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study. Endocr J. 2015; 63(2):143-9. DOI: 10.1507/endocrj.EJ15-0441. View

10.

McGill P, Harden R, Robertson I, Shimmins J . A comparison between the uptake of technetium-99m and iodine-131 by the thyroid gland. J Endocrinol. 1971; 49(3):531-6. DOI: 10.1677/joe.0.0490531. View

11.

Ross D, Burch H, Cooper D, Greenlee M, Laurberg P, Maia A . 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10):1343-1421. DOI: 10.1089/thy.2016.0229. View

Cut off Value of Technetium Uptake in the Differential Diagnosis of Graves Disease and Subacute Thyroiditis